|
Target Audience
This activity has been designed to meet the educational needs of hepatologists,
gastroenterologists and physician assistants involved in the management of chronic hepatitis B.
Goal Statement
To provide important clinical data on the management of HBV.
Educational Objectives
Upon completion of this activity, participants should be better able to:
- Discuss approaches for managing resistance in HBV patients
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas
and Policies of the Accreditation Council for Continuing Education (ACCME) through the sponsorship of Purdue
University, an equal opportunity, equal access institution. Purdue University is accredited by the ACCME to
provide continuing medical education for physicians.
Credit Designation
Purdue University designates this educational activity for a maximum of .5 AMA PRA
Category 1 Credit (s)™. Physicians should only claim credit commensurate with the extent of their participation
in the activity.
Release - December 31, 2007
Expiration - December 31, 2008
Faculty Disclosures
Dr. Mark Sulkowski has received consulting fees from: Abbott, Roche, Schering-Plough. Dr. Mark Sulkowski has received non-CME fees from Roche, Schering-Plough, Abbott. Dr. Mark Sulkowski has contracted research with: Human Genome Sciences, Valeant and Idenix Pharmaceuticals.
Program Support
This program is supported by an education grant from Bristol-Myers Squibb and Gilead Pharmaceuticals
|
